Related Experiment Video
Updated: Nov 5, 2025

08:54
Functional Human Liver Preservation and Recovery by Means of Subnormothermic Machine Perfusion
Published on: April 27, 2015
17.1K
Cost Structures of US Organ Procurement Organizations
Philip J Held1, Jennifer L Bragg-Gresham2, Thomas G Peters3
1Division of Nephrology, Stanford University of Medicine, Palo Alto, CA.
Transplantation
|May 14, 2021
Summary
Organ procurement organizations (OPOs) are financially secure, with profits and assets indicating finances are not causing organ shortages. High-cost OPOs differ significantly from lower-cost ones in several operational aspects.
Area of Science:
- Health Economics
- Transplant Logistics
- Public Health Policy
Background:
- Organ procurement organizations (OPOs) manage deceased donor organ procurement in the US.
- OPOs operate as not-for-profit federal contractors with exclusive geographic territories.
- Understanding OPO operational costs is crucial for national organ donation analysis.
Purpose of the Study:
- To conduct a national analysis of organ procurement organization (OPO) costs.
- To investigate factors contributing to cost variations among OPOs.
- To assess the financial health and market dynamics of OPOs.
Main Methods:
- Utilized five years of data (2013-2017) from 51 of 58 OPOs, obtained via Freedom of Information Act (FOIA).
- Developed and applied a generalized 15-factor cost regression model.
- Validated selected cost measures against IRS forms.
Main Results:
- Deceased donor organ procurement is a $1 billion/year operation; over 60% of organ cost is overhead.
- OPOs average $2.3 million/year profit and $45 million/year in assets, growing at 9%/year.
- Highest-cost OPOs are smaller, import more kidneys, have higher labor and support personnel costs, and spend more on professional education.
Conclusions:
- OPO financial security and asset accumulation suggest finances do not drive organ shortages.
- High asset levels may deter new market entrants.
- Current allocation models may subsidize tissue procurement, and professional education spending does not decrease procurement costs.
Related Concept Videos
Kidney Transplant I: Introduction
106
A kidney transplant is a surgical approach that involves replacing a non-functioning kidney with a healthy one from a donor. This procedure is often a treatment option for end-stage renal disease (ESRD) patients. The method requires careful recipient selection, including evaluating various medical and psychosocial factors. These criteria vary between transplant centers but generally include assessments of the patient's overall health, adherence to medical recommendations, and lifestyle...
106
Tissue Transplantation
669
Tissue transplantation is a significant medical procedure involving the transfer of cells, tissues, or organs from a donor to a recipient, with the primary aim of restoring lost functions. This procedure is crucial in treating a broad spectrum of diseases, including kidney diseases, liver failure, heart disease, and certain types of cancers.
The Biology of Tissue Transplantation
The biology of tissue transplantation hinges on the Major Histocompatibility Complex (MHC) molecules. These molecules...
The Biology of Tissue Transplantation
The biology of tissue transplantation hinges on the Major Histocompatibility Complex (MHC) molecules. These molecules...
669
Kidney Transplant II: Surgical Procedure
109
Preoperative ManagementThe primary goals of preoperative management in kidney transplantation are to optimize the patient’s metabolic state and prepare them for surgery through diet adjustments, necessary dialysis, and tailored medical treatment. This phase also involves comprehensive infection screening and patient education about the surgical procedure and postoperative care to improve outcomes and adherence.Medical ManagementA comprehensive evaluation is required for both the living...
109

